Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Krumholz

Showing results (521-530 of 2,207) with videos related to

Pageof 221
Sort By:
Chest|October 1, 1970
Giant thymomaW F Smith, R A DeWall, R A Krumholz
Spine|February 8, 2014
Moving forward from rhBMP-2: open science and data sharingJeffrey B Low, Joseph S Ross, Harlan M Krumholz
The American Journal of Medicine|September 6, 2016
Healthcare Disparities Affecting Americans in the US Territories: A Century-Old DilemmaOrlando Rodríguez-Vilá, Sudhakar V Nuti, Harlan M Krumholz
JAMA|September 7, 2016
Informed Consent and the Reasonable-Patient Standard-ReplyErica S Spatz, Harlan M Krumholz, Benjamin W Moulton
Infection and Immunity|September 24, 2005
Toll-like receptor 2 regulates interleukin-1beta-dependent cardiomyocyte hypertrophy triggered by Trypanosoma cruziChristine A Petersen, Katherine A Krumholz, Barbara A Burleigh
Archives of Internal Medicine|June 29, 2011
Study of neurontin: titrate to effect, profile of safety (STEPS) trial: a narrative account of a gabapentin seeding trialSamuel D Krumholz, David S Egilman, Joseph S Ross
JAMA|March 20, 2014
Strategies to reduce heart failure readmissionsElizabeth H Bradley, Leslie A Curry, Harlan M Krumholz
Lancet (London, England)|January 8, 2016
Time for a prepublication culture in clinical research?Michael S Lauer, Harlan M Krumholz, Eric J Topol
Lancet (London, England)|October 17, 2018
Prevalence and control of hypertension - Authors' replyJiapeng Lu, Yuan Lu, Harlan M Krumholz, et al.
JAMA Internal Medicine|March 14, 2022
A Different Case of Penumbra-Reply: A Japanese Framework for Safe and Expedited Access to High-Risk Medical DevicesKushal T Kadakia, Joseph S Ross, Harlan M Krumholz
Pageof 221

Showing results (521-530 of 2,207) with videos related to

Sort By:
Pageof 221
Chest|October 1, 1970
Giant thymomaW F Smith, R A DeWall, R A Krumholz
Spine|February 8, 2014
Moving forward from rhBMP-2: open science and data sharingJeffrey B Low, Joseph S Ross, Harlan M Krumholz
The American Journal of Medicine|September 6, 2016
Healthcare Disparities Affecting Americans in the US Territories: A Century-Old DilemmaOrlando Rodríguez-Vilá, Sudhakar V Nuti, Harlan M Krumholz
JAMA|September 7, 2016
Informed Consent and the Reasonable-Patient Standard-ReplyErica S Spatz, Harlan M Krumholz, Benjamin W Moulton
Infection and Immunity|September 24, 2005
Toll-like receptor 2 regulates interleukin-1beta-dependent cardiomyocyte hypertrophy triggered by Trypanosoma cruziChristine A Petersen, Katherine A Krumholz, Barbara A Burleigh
Archives of Internal Medicine|June 29, 2011
Study of neurontin: titrate to effect, profile of safety (STEPS) trial: a narrative account of a gabapentin seeding trialSamuel D Krumholz, David S Egilman, Joseph S Ross
JAMA|March 20, 2014
Strategies to reduce heart failure readmissionsElizabeth H Bradley, Leslie A Curry, Harlan M Krumholz
Lancet (London, England)|January 8, 2016
Time for a prepublication culture in clinical research?Michael S Lauer, Harlan M Krumholz, Eric J Topol
Lancet (London, England)|October 17, 2018
Prevalence and control of hypertension - Authors' replyJiapeng Lu, Yuan Lu, Harlan M Krumholz, et al.
JAMA Internal Medicine|March 14, 2022
A Different Case of Penumbra-Reply: A Japanese Framework for Safe and Expedited Access to High-Risk Medical DevicesKushal T Kadakia, Joseph S Ross, Harlan M Krumholz
Pageof 221